MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease
Open Access
- 2 October 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
Abstract
One of the major challenges in chronic Chagas disease is to understand the mechanisms that predict the clinical evolution from asymptomatic to severe cardiac clinical forms. Our cohort consisted of twenty-eight Chagas disease patients followed for twenty years. Plasma levels of MMP-2 and MMP-9 gelatinases and TIMPs were evaluated by multiplexed immunoassay at two points in time with an average interval of six years. MMP-2 plasma levels, but not MMP-9, increased in cardiac patients over time. TIMP-1 levels diminished in cardiac patients, while TIMP-3 dropped in asymptomatic patients in the course of the evaluated interval. An inversion of time lines was observed relative to the clinical asymptomatic and cardiac forms for MMP-2. Receiver Operating Characteristic (ROC) curve analysis identified MMP-2 as a biomarker to distinguish asymptomatic from cardiac clinical forms, while MMP-9 is a biomarker that segregates infected from non-infected patients. We have pointed out that MMP-2 and MMP-9 together can predict clinical evolution in Chagas disease. MMP-2 was suggested as a biomarker for fibrosis replacement in early remodeling and a sensitive predictor for initial changes in asymptomatic patients that may evolve into the cardiac clinical form. MMP-9 seems to be a biomarker for late fibrosis and severe cardiac remodeling in cardiac patients.Keywords
This publication has 37 references indexed in Scilit:
- Chagas DiseaseJACC, 2013
- Matrix metalloproteinases as therapeutic targets in protozoan parasitic infectionsPharmacology & Therapeutics, 2012
- Tissue inhibitors of metalloproteinasesGenome Biology, 2011
- Matrix Metalloproteinase (MMP)-9, but Not MMP-2, Is Involved in the Development and Progression of C Protein-Induced Myocarditis and Subsequent Dilated CardiomyopathyThe Journal of Immunology, 2009
- Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrixCardiovascular Research, 2009
- Increased Activities of Cardiac Matrix Metalloproteinases Matrix Metalloproteinase (MMP)–2 and MMP‐9 Are Associated with Mortality during the Acute Phase of ExperimentalTrypanosoma cruziInfectionThe Journal of Infectious Diseases, 2008
- The relationship between myocardial extracellular matrix remodeling and ventricular function☆European Journal of Cardio-Thoracic Surgery, 2006
- Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulationCardiovascular Research, 2006
- The indeterminate form of human chronic Chagas' disease: a clinical epidemological reviewRevista da Sociedade Brasileira de Medicina Tropical, 1989
- Acute Chagas' diseaseMemórias do Instituto Oswaldo Cruz, 1984